Preclinical research proteins with enhanced activity & stability

The development of recombinant proteins is performed using different production expression systems, including the mammalian cell lines CHO and HEK 293. The mammalian cell lines allow AdipoGen Life Sciences to produce exogenous recombinant proteins secreted into the cell medium with post-translational modifications and glycosylations closer to endogenous proteins compared to productions in E. coli. However, for some difficult-to-produce in mammalian cells proteins, we also use bacteria (E. coli) and/or insect cells as a host. AdipoGen Life Sciences’ first goal is to provide high purity, low endotoxin and biologically active recombinant proteins, leveraging its in-house protein technologies.

Recombinant proteins are used throughout the life science academia and industry in a plethora of applications. They elicit their mechanism of action by activating signaling pathways through binding to specific cell-surface receptors. Their use ranges from cell culture to bioprocessing and advanced cell and gene therapy. A defined composition of the cell culture medium to guarantee batch-to-batch reproducibility has become inevitable. The development of animal-component-free recombinant proteins eliminates the risk of contamination that has been associated with animal and human serum-derived media.

TNF ligands multimeric proteins

COMP proteins

Monomeric proteins fused to Fc (KIH-technology)

Fc-fusion proteins (wild-type or non-lytic)

Proteins with site-directed mutations

Selected other specialty proteins

For more information visit AdipoGen Life Sciences’ landing page proteins with enhanced activity and stability.